← Studies & programmes
Myelin repairTesting whether it helps patientsAccepting participants
Metformin in older adults with MS: a Phase 2 study
Published by MyelinWatch:
Metformin in aging MS · Researchers are testing metformin in adults aged 55–75 with MS, measuring safety and changes with brain scans and specialised myelin-related measures.
What is being studied
Researchers are testing metformin in adults aged 55–75 with MS, measuring safety and changes with brain scans and specialised myelin-related measures.
Research stage
Testing whether it helps patients
The current listing is open to participants.
What we know so far
The Phase 2 study is currently open to participants at a centre in Buffalo, United States. Results are not yet available.
What this means for patients today
The study is not a treatment recommendation. Participation depends on the study’s eligibility rules and site; no Greek site is listed.
- Treatment or approach
- Metformin • people aged 55–75
- How it is intended to work
- Tests whether metformin can improve repair processes that weaken with age
- Where the study is running
- Centre in Buffalo, United States • none in Greece
- Published by MyelinWatch
- Last substantive MyelinWatch update